Today, Friday, the British government announced that it has requested its Medicines Regulatory Authority to evaluate the emerging coronavirus vaccine, developed by the British AstraZeneca Laboratory and the University of Oxford, in preparation for its launch on the market.
“We have officially requested the Medicines Regulatory Authority to evaluate the Oxford / AstraZeneca vaccine and determine whether it meets stringent safety standards,” Health Minister Matt Hancock said in a statement. He added that if approved, this would constitute “an important step towards launching a vaccine as soon as possible.”The United Kingdom, which is the country most affected by the pandemic in Europe, with more than 57,000 deaths due to the virus, is also “the first country in the world to sign a contract with AstraZeneca and the University of Oxford, guaranteeing it access to a hundred million doses,” according to the Ministry of Health.
If the vaccine is approved, 4 million doses will be delivered to the UK before the end of the year, followed by another 40 million doses before the end of March 2021.
And the president of AstraZeneca announced Thursday that more research is needed on the vaccine that the company is developing to fight Covid-19, after questions emerged about the protection it could provide.